@RepeatDx

RepeatDx is an accredited clinical diagnostics laboratory using Flow FISH analysis for telomere length measurement🧬(2 and 6 - Panel). Helping #IPF🫁 & #DC🩸.

 Greater Vancouver
repeatdx.com
Joined November 2015
  • Tweets1.5K
  • Following3.2K
  • Followers706
520Media
Repeat Dx is a clinical diagnostics laboratory committed to the utmost quality of clinical service for telomere length testing🧬.The Flow FISH method (2-panel and 6-panel) aids in disease course prediction and guides treatment decisions for DC🩸and PF🫁. bit.ly/3R2SH9F
1
5
1,753
What a remarkable year it's been for Repeat Diagnostics! As we look ahead to 2025, we're excited to celebrate a major milestone—our 20th anniversary. Wishing you a joyful holiday season and a fantastic new year! Merry Lab Celebration! ▶️bit.ly/4iEvSGS
145
Repeat Diagnostics 🇨🇦 retweeted
Dr. David J. Young, MD PhD@DrDavidJYoung8 Dec 2024
Follow up of @nih_nhlbi Danazol for #TBD by @NickLeeMD : Danazol remains safe and effective. Most require life-long treatment, but organ dysfunction and infection (esp pulmonary) continues. Absent other risks (e.g., immune AA) clonal expansion is not seen. #ASH24 #HemeTwitter
6
15
768
Repeat Diagnostics 🇨🇦 retweeted
Emma M. Groarke@emmamgroarke8 Dec 2024
Amazing talk from our @nih_nhlbi fellow @NickLeeMD presenting long-term results from our high-dose Danazol protocol for patients with #TBD. #ASH24 @ASH_hematology @NCICCR_MOS @NealSYoung1 @fergutierrezro1 @bhavishap29 @TeamTelomereInc
1
9
25
1,180
Repeat Diagnostics 🇨🇦 retweeted
Emma M. Groarke@emmamgroarke5 Dec 2024
A nice commentary in this issue of @BloodJournal for our paper looking at the role of #ClonalHematopoiesis in #TBD from @Chris_R_Reilly and @myllymaki_mikko - a somatic symphony; telomeres and CH! ashpublications.org/blood/ar… @fergutierrezro1 @SharonSavageMD ashpublications.org/blood/ar…
17
1
37
5,127
Repeat Diagnostics 🇨🇦 retweeted
Fernanda Gutierrez-Rodrigues@fergutierrezro16 Dec 2024
Our #ClonalHematopoiesis paper is finally featured in the latest @BloodJournal issue! A huge collaboration among #TBD experts @emmamgroarke @NealSYoung1 @SharonSavageMD @CarmemBonfim1 @TeamTelomereInc ashpublications.org/blood/ar… @nih_nhlbi #BMFsm #MDSsm
1
9
30
1,238
Repeat Diagnostics 🇨🇦 retweeted
Emma M. Groarke@emmamgroarke4 Dec 2024
For #GivingTuesday consider donating to @TeamTelomereInc who provide excellent support to our #telomere biology patients! 🧬
Team Telomere@TeamTelomereInc2 Dec 2024
Tomorrow is Giving Tuesday! Help us celebrate our 15th Birthday with a donation starting today: bit.ly/TTGT24 #TeamTelomere15 #TelomereBiologyDisorder #GivingTuesday2024

Help us change the future of Telomere Biology Disorders

Celebrate 15 Years of Team Telomere this Giving Tuesday! This Giving Tuesday, we are celebrating a milestone — Team Telomere Turns 15! Over the past 15 years, the impact of our community has been...

teamtelomere.networkforgood.com
1
3
429
New to pulmonary fibrosis? The @PFFORG is here to guide you! They've compiled trusted resources and expert insights for newly diagnosed patients. Hats off to PFF for their incredible work! 💙 bit.ly/4gcSD2z #Telomere #IPF
111
Repeat Diagnostics 🇨🇦 retweeted
CHEST
@accpchest13 Nov 2024
What is the clinical impact of telomere length testing on the management of #InterstitialLungDisease? Read the full research in the November issue of the journal CHEST®: hubs.la/Q02XYDQB0 #MedEd #MedTwitter
20
1
37
3,282
Repeat Diagnostics 🇨🇦 retweeted
Team Telomere@TeamTelomereInc20 Nov 2024
Today we are sharing our Clinical Guidelines & the impact they have made across the world. To order or download a copy of the CGs or our One Pagers head to our website site today ➡️ teamtelomere.org/diagnosis-m… #TBDawareness #TeamTelomere15
3
4
296
Repeat Diagnostics 🇨🇦 retweeted
Emma M. Groarke@emmamgroarke15 Nov 2024
Replying to @SharonSavageMD
@SharonSavageMD from @theNCI giving an excellent talk on non-hematology complications of #telomere biology disorders. Highlights include liver and lung disease, osteoporoses, and solid cancer risk. @TeamTelomereInc #ESHBMFS2024 @ESHaematology
5
13
704
Kudos to @TeamTelomereInc 👏for going beyond just raising awareness about Telomere Biology Disorder (TBD). They're connecting top experts in both clinical and research fields.
University of Minnesota Medical School@umnmedschool14 Nov 2024
We are excited to announce that the University of Minnesota and @MHealthFairview have been recognized as a @TeamTelomereInc Center of Excellence for Telomere Biology Disorders (TBDs)! Read more: bit.ly/40JECVF. #Telomere | #TBDs
1
228
Repeat Diagnostics 🇨🇦 retweeted
Emma M. Groarke@emmamgroarke15 Nov 2024
My colleague @fergutierrezro1 giving an excellent talk at #ESHBMFS2024 on the clinical implications of clonal hematopoiesis in #telomere biology disorders 🧬; dependent on specific mutation with U2AF1, TP53, and chr1+ associated with #MDSsm and #AMLsm. @nih_nhlbi @ESHaematology
2
8
28
1,380
Repeat Diagnostics 🇨🇦 retweeted
Emma M. Groarke@emmamgroarke15 Nov 2024
Very nice talk from Fabian Beier @RWTH on #HCT in #telomere biology disorders; ongoing high morbidity and mortality related to secondary organ damage. Non-alkylator/TBI regimens and gene therapy promising. @TeamTelomereInc @KMyersBMT @Agarwal_Lab @ESHaematology #ESHBMFS2024
1
7
16
1,972
November marks Telomere Biology Disorder (TBD) Awareness Month🧬—a time dedicated to illuminating a complex yet critical area of health that impacts many lives. bit.ly/48JW9iI #TBDMonth, #Telomeres, #Telomere, #IPF
For medical professionals, patients, families, and researchers, Telomere Biology Disorder Month offers an opportunity to come together and explore the significance of telomere length in clinical settings, the importance of diagnosis, and the potential for advancements in treatments. In this blog post, we explore these themes and offer insights into how telomere research is paving the way for better outcomes in treatments.

ALT For medical professionals, patients, families, and researchers, Telomere Biology Disorder Month offers an opportunity to come together and explore the significance of telomere length in clinical settings, the importance of diagnosis, and the potential for advancements in treatments. In this blog post, we explore these themes and offer insights into how telomere research is paving the way for better outcomes in treatments.

3
5
316
Repeat Diagnostics 🇨🇦 retweeted
Emma M. Groarke@emmamgroarke7 Nov 2024
Our lab will present two #telomere biology disorder abstracts this year at @ASH_hematology #ASH24. First, our @nih_nhlbi fellow @NickLeeMD will be presenting the long-term results of our phase II trial using Danazol @ the Sunday oral #IBMFS session. ash.confex.com/ash/2024/webp… 1/2 👇
5
9
37
2,432
Rare germline pathogenic variants (GPVs) in #telomere maintenance genes can lead to telomere biology disorders (TBDs) like bone marrow failure and #IPF, while others cause cancer predisposition with long #telomeres (CPLT). Excellent article from CCCTAA👏 onlinelibrary.wiley.com/doi/…

Different phenotypes with different endings—Telomere biology disorders and cancer predisposition...

Germline pathogenic variants in genes impacting telomere maintenance and function have varied impacts on telomere biology and cellular and clinical phenotypes as illustrated here.

onlinelibrary.wiley.com
4
6
306
Repeat Diagnostics 🇨🇦 retweeted
ERS@EuroRespSoc29 Oct 2024
New ERS Interactive Education case-based video now available: ‘The challenges of diagnosing ILD’. The 2nd video in this new series will improve participants’ ability to interpret chest x-rays & HRCT patterns associated with ILDs. channel.ersnet.org/channel-2…
6
1
12
2,407
Repeat Diagnostics 🇨🇦 retweeted
Team Telomere@TeamTelomereInc9 Oct 2024
Welcome to Scientific Summit Scenes where we share highlights from #TTSummit24! Today we’re spotlighting Session 2: Clonal Hematopoiesis in #TBDs. Our attendees explored the landscape of clonal hematopoiesis in TBDs and its clinical implications. Stay tuned for more scenes!
There is a gradient border around the image. The image shows a man with a microphone in hand pointing to a screen while individuals around are looking at him and the screen. The top half of the graphic has the text "Scientific Summit Series Session 2: Clonal Hematopoiesis in Telomere Biology Disorders"

ALT There is a gradient border around the image. The image shows a man with a microphone in hand pointing to a screen while individuals around are looking at him and the screen. The top half of the graphic has the text "Scientific Summit Series Session 2: Clonal Hematopoiesis in Telomere Biology Disorders"

There is text reading “Session Presentations” followed by “Chaired by Dr. Alison Bertuch (Texas Childrens) and Dr. Tim Olson (Children's Hospital of Philadelphia) The Landscape of Clonal Hematopoiesis in Pediatric and Adult Telomere Biology Disorders, Dr. Chris Sande (Seattle Children's Hospital) Clonal Landscape and Clinical Outcomes of Telomere Biology Disorders, Dr. Fernanda Gutierrez-Rodrigues (NHLBI) Adaptive and Maladaptive Clonal Hematopoiesis Spectrum in Telomere Biology Disorders, Dr. Terra Lasho (Mayo Clinic) SF3B1 Mutant Clonal Hematopoiesis as a Unique Mechanism of Ineffective Erythropoiesis and Somatic Rescue in Patients with Telomere Biology Disorders, Dr. Abhishek Mangaonkar (Mayo Clinic) Splicing Alterations Caused by U2AF1MT-S34 Modify the Transcriptome of POT1 in Patients with Telomere Biology Disorders, Dr. Alejandro Ferrer (Mayo Clinic)”

ALT There is text reading “Session Presentations” followed by “Chaired by Dr. Alison Bertuch (Texas Childrens) and Dr. Tim Olson (Children's Hospital of Philadelphia) The Landscape of Clonal Hematopoiesis in Pediatric and Adult Telomere Biology Disorders, Dr. Chris Sande (Seattle Children's Hospital) Clonal Landscape and Clinical Outcomes of Telomere Biology Disorders, Dr. Fernanda Gutierrez-Rodrigues (NHLBI) Adaptive and Maladaptive Clonal Hematopoiesis Spectrum in Telomere Biology Disorders, Dr. Terra Lasho (Mayo Clinic) SF3B1 Mutant Clonal Hematopoiesis as a Unique Mechanism of Ineffective Erythropoiesis and Somatic Rescue in Patients with Telomere Biology Disorders, Dr. Abhishek Mangaonkar (Mayo Clinic) Splicing Alterations Caused by U2AF1MT-S34 Modify the Transcriptome of POT1 in Patients with Telomere Biology Disorders, Dr. Alejandro Ferrer (Mayo Clinic)”

There are four images. Left to right and up to down, they showcase 1) A man with a microphone is seen gesturing as he talks. There is a slide with scientific information behind him. 2) A woman is seen seated on a chair. She is holding a mic and smiling. 3) A man is seen gesturing with two hands while he is speaking from his chair. 4) A man with a microphone is seen gesturing as he talks. There is a slide with scientific information behind him.

ALT There are four images. Left to right and up to down, they showcase 1) A man with a microphone is seen gesturing as he talks. There is a slide with scientific information behind him. 2) A woman is seen seated on a chair. She is holding a mic and smiling. 3) A man is seen gesturing with two hands while he is speaking from his chair. 4) A man with a microphone is seen gesturing as he talks. There is a slide with scientific information behind him.

There are four images. Left to right and up to down, they showcase 1) There is a woman with a microphone seen speaking in front of a laptop. A screen with scientific information is behind her. 2) A man holding a microphone and speaking. 3) A man looking a head with a microphone in hand as he speaks. 4) A man laughing as he is seated at a table.

ALT There are four images. Left to right and up to down, they showcase 1) There is a woman with a microphone seen speaking in front of a laptop. A screen with scientific information is behind her. 2) A man holding a microphone and speaking. 3) A man looking a head with a microphone in hand as he speaks. 4) A man laughing as he is seated at a table.

3
9
523
Repeat Diagnostics 🇨🇦 retweeted
Fernanda Gutierrez-Rodrigues@fergutierrezro125 Sep 2024
CH in Telomere biology disorders as predictors of #MDS! As Chr1q+, U2AF1-S34 leads to TP53 pathway deregulation in HSCs with dysfunctional telomeres. Now online! #TBD #clonalHematopoiesis
Emma M. Groarke@emmamgroarke24 Sep 2024
Replying to @emmamgroarke
The clonal landscape is dominated by mutations in PPM1D, POT1, TERTp and U2AF1. Patients who develop U2AF1, TP53, or chromosome 1q gain, have a higher risk of cancer development.
5
26
1,937
87
Load more